Insight Report 2 minutes PremiumRite Aid (RAD) 2Q17 RESULTS: ACQUISITION ON TRACK TO CLOSE IN 2H16 Coresight Research September 23, 2016 Executive Summary Rite Aid reported adjusted EPS of $0.03, beating the $0.02 consensus estimate and up from last year’s $0.02. Businesses that contributed to the positive results included its EnvisionRX PBM, and its strong front-end segment. There was some improvement in prescription drug costs, which was offset by challenging reimbursement rates. The company continues to believe that the announced acquisition of Rite Aid by Walgreens will close in the second half of 2016. This report is for paying subscribers only. Already a paying subscriber? Please log in to see the entire report.If you wish to learn more about our subscription plans and become a paying subscriber, click here. This document was generated for Other research you may be interested in: The Evolution of Checkout: Trends and Innovations for a Seamless Shopping ExperienceConsumers Report Strong Financial Health: US Consumer Survey InsightsRetailers Harness Seasonal Shifts: China Consumer TrackerEarnings Insights 4Q22, Week 6: Burlington, Dollar Tree, Kroger and Urban Outfitters Post Strong Sales Growth; Carter’s, Kohl’s, Lowe’s and Qurate Retail See Sales Decline
